These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 27893691)

  • 1. Valuable hematological indicators for the diagnosis and severity assessment of Chinese children with community-acquired pneumonia: Prealbumin.
    Ning J; Shao X; Ma Y; Lv D
    Medicine (Baltimore); 2016 Nov; 95(47):e5452. PubMed ID: 27893691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic value of blood parameters for community-acquired pneumonia.
    Huang Y; Liu A; Liang L; Jiang J; Luo H; Deng W; Lin G; Wu M; Li T; Jiang Y
    Int Immunopharmacol; 2018 Nov; 64():10-15. PubMed ID: 30144639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation between mycoplasma and viral community-acquired pneumonia in children with lobe or multi foci infiltration: a retrospective case study.
    Guo WL; Wang J; Zhu LY; Hao CL
    BMJ Open; 2015 Jan; 5(1):e006766. PubMed ID: 25596200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Distance to Health Transcriptional Score and Disease Severity in Children Hospitalized With Community-Acquired Pneumonia.
    Wallihan RG; Suárez NM; Cohen DM; Marcon M; Moore-Clingenpeel M; Mejias A; Ramilo O
    Front Cell Infect Microbiol; 2018; 8():382. PubMed ID: 30425971
    [No Abstract]   [Full Text] [Related]  

  • 5. The usefulness of serum procalcitonin, C-reactive protein, soluble triggering receptor expressed on myeloid cells 1 and Clinical Pulmonary Infection Score for evaluation of severity and prognosis of community-acquired pneumonia in elderly patients.
    Wang Y; Zhang S; Li L; Xie J
    Arch Gerontol Geriatr; 2019; 80():53-57. PubMed ID: 30366226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison study between GeXP-based multiplex-PCR and serology assay for Mycoplasma pneumoniae detection in children with community acquired pneumonia.
    Wang L; Feng Z; Zhao M; Yang S; Yan X; Guo W; Shi Z; Li G
    BMC Infect Dis; 2017 Jul; 17(1):518. PubMed ID: 28743259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application value of antibody titres and RNA detection in the early prediction of Mycoplasma pneumoniae pneumonia in children: a retrospective study.
    Tuo W; Guo X; Wu M; Xie S; Shen X; Wang J; Cai Q; Yuan C; Yao C; Xiang Y
    BMC Infect Dis; 2023 Apr; 23(1):220. PubMed ID: 37029345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycoplasma pneumoniae as a causative agent of community-acquired pneumonia in children: clinical features and laboratory diagnosis.
    Medjo B; Atanaskovic-Markovic M; Radic S; Nikolic D; Lukac M; Djukic S
    Ital J Pediatr; 2014 Dec; 40():104. PubMed ID: 25518734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of mean platelet volume in the determination of community acquired pneumonia in children.
    Karadag-Oncel E; Ozsurekci Y; Kara A; Karahan S; Cengiz AB; Ceyhan M
    Ital J Pediatr; 2013 Mar; 39():16. PubMed ID: 23497478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A three-step diagnosis of pediatric pneumonia at the emergency department using clinical predictors, C-reactive protein, and pneumococcal PCR.
    Alcoba G; Keitel K; Maspoli V; Lacroix L; Manzano S; Gehri M; Tabin R; Gervaix A; Galetto-Lacour A
    Eur J Pediatr; 2017 Jun; 176(6):815-824. PubMed ID: 28474099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia.
    Almirall J; Bolíbar I; Toran P; Pera G; Boquet X; Balanzó X; Sauca G;
    Chest; 2004 Apr; 125(4):1335-42. PubMed ID: 15078743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers and Disease Severity in Children With Community-Acquired Pneumonia.
    Florin TA; Ambroggio L; Brokamp C; Zhang Y; Rattan M; Crotty E; Belsky MA; Krueger S; Epperson TN; Kachelmeyer A; Ruddy R; Shah SS
    Pediatrics; 2020 Jun; 145(6):. PubMed ID: 32404432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of lipocalin-2 and syndecan-4 levels to differentiate bacterial from viral infection in children with community-acquired pneumonia.
    Esposito S; Bianchini S; Gambino M; Madini B; Di Pietro G; Umbrello G; Presicce ML; Ruggiero L; Terranova L; Principi N
    BMC Pulm Med; 2016 Jul; 16(1):103. PubMed ID: 27439403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Prealbumin Improves the Sensitivity of Pneumonia Severity Index in Predicting 30-day Mortality of CAP Patients.
    Zhang HF; Li LQ; Ge YL; Zhang JB; Fu AS; Liu CH; Shao DF; Bai J; Zhu XY
    Clin Lab; 2020 May; 66(5):. PubMed ID: 32390376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in inflammatory marker patterns for adult community-acquired pneumonia patients induced by different pathogens.
    Liu M; Li H; Xue CX; Gu L; Qu JX; Yu XM; Wang YM; Liu YM; Cao B
    Clin Respir J; 2018 Mar; 12(3):974-985. PubMed ID: 28139879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of serum procalcitonin and C-reactive protein in severity assessment of community-acquired pneumonia in children.
    Agnello L; Bellia C; Di Gangi M; Lo Sasso B; Calvaruso L; Bivona G; Scazzone C; Dones P; Ciaccio M
    Clin Biochem; 2016 Jan; 49(1-2):47-50. PubMed ID: 26386341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of 'atypical pathogens' among adult hospitalized patients with community-acquired pneumonia.
    Lui G; Ip M; Lee N; Rainer TH; Man SY; Cockram CS; Antonio GE; Ng MH; Chan MH; Chau SS; Mak P; Chan PK; Ahuja AT; Sung JJ; Hui DS
    Respirology; 2009 Nov; 14(8):1098-105. PubMed ID: 19818051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First report on prevalence and risk factors of severe atypical pneumonia in Vietnamese children aged 1-15 years.
    Huong Ple T; Hien PT; Lan NT; Binh TQ; Tuan DM; Anh DD
    BMC Public Health; 2014 Dec; 14():1304. PubMed ID: 25524126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Cytokine and Chemokine Signatures as Potential Biomarkers of Childhood Community-acquired Pneumonia Severity: A Nested Cohort Study in India.
    Saghafian-Hedengren S; Mathew JL; Hagel E; Singhi S; Ray P; Ygberg S; Nilsson A
    Pediatr Infect Dis J; 2017 Jan; 36(1):102-108. PubMed ID: 27956727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycoplasma pneumoniae and Chlamydophila pneumoniae in children with community-acquired pneumonia in Thailand.
    Lochindarat S; Suwanjutha S; Prapphal N; Chantarojanasiri T; Bunnag T; Deerojanawong J; Kunakorn M; Srisan P
    Int J Tuberc Lung Dis; 2007 Jul; 11(7):814-9. PubMed ID: 17609060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.